Comparing Diabetes Risk Assessment Methods
Author Information
Author(s): Shafizadeh Tracy B., Moler Edward J., Kolberg Janice A., Nguyen Uyen Thao, Hansen Torben, Jorgensen Torben, Pedersen Oluf, Borch-Johnsen Knut
Primary Institution: Tethys Bioscience, Emeryville, California, United States of America
Hypothesis
Is the Diabetes Risk Score (DRS) more accurate than the Metabolic Syndrome (MetS) in predicting the risk of developing type 2 diabetes?
Conclusion
The Diabetes Risk Score (DRS) provides a more accurate assessment of diabetes risk than the Metabolic Syndrome (MetS).
Supporting Evidence
- DRS had a significantly lower false positive rate compared to MetS.
- When matched for sensitivity, DRS had a higher specificity than MetS.
- The relative risk of T2DM differed by 15 fold between low and high DRS risk groups.
Takeaway
This study found that a special score based on blood tests can better predict who will get diabetes compared to just counting risk factors like weight and blood pressure.
Methodology
The study evaluated the DRS in 4,128 non-diabetic subjects from the Inter99 cohort, comparing its predictive accuracy to that of MetS.
Potential Biases
Potential bias due to the training population being a small portion of the subjects used in the current study.
Limitations
The DRS algorithm was originally trained on a subset of the Inter99 population, which may introduce bias.
Participant Demographics
Danish adults aged 30-60 years, with a focus on non-diabetic individuals.
Statistical Information
P-Value
0.008
Statistical Significance
p=0.008
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website